Kornitzer Capital Management Raised By $1.23 Million Its Emerson Electric Co (EMR) Stake, Accelerate Diagnostics (AXDX) Has 1.69 Sentiment

June 20, 2017 - By Marguerite Chambers

Accelerate Diagnostics, Inc. is an in vitro diagnostics firm engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The company has market cap of $1.59 billion. The Company’s in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify , infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It currently has negative earnings. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results.

Kornitzer Capital Management Inc increased Emerson Electric Co (EMR) stake by 22.13% reported in 2016Q4 SEC filing. Kornitzer Capital Management Inc acquired 22,450 shares as Emerson Electric Co (EMR)’s stock declined 4.02%. The Kornitzer Capital Management Inc holds 123,915 shares with $6.91M value, up from 101,465 last quarter. Emerson Electric Co now has $39.83B valuation. The stock increased 1.15% or $0.7 during the last trading session, reaching $61.38. About shares traded. Emerson Electric Co. (NYSE:EMR) has risen 18.47% since June 20, 2016 and is uptrending. It has outperformed by 1.77% the S&P500.

Among 22 analysts covering Emerson Electric Co. (NYSE:EMR), 5 have Buy rating, 2 Sell and 15 Hold. Therefore 23% are positive. Emerson Electric Co. had 45 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Emerson Electric Co. (NYSE:EMR) earned “Hold” rating by RBC Capital Markets on Wednesday, April 12. The stock of Emerson Electric Co. (NYSE:EMR) has “Hold” rating given on Friday, March 3 by HSBC. Citigroup maintained it with “Sell” rating and $49 target in Tuesday, April 19 report. The stock of Emerson Electric Co. (NYSE:EMR) earned “Hold” rating by TheStreet on Friday, September 4. As per Wednesday, August 5, the company rating was maintained by Canaccord Genuity. On Wednesday, May 11 the stock rating was upgraded by Argus Research to “Buy”. Citigroup initiated the stock with “Sell” rating in Thursday, January 21 report. On Wednesday, October 12 the stock rating was downgraded by UBS to “Sell”. The rating was upgraded by Goldman Sachs to “Neutral” on Friday, January 27. Cowen & Co maintained the stock with “Hold” rating in Wednesday, April 26 report.

Investors sentiment decreased to 0.81 in Q4 2016. Its down 0.18, from 0.99 in 2016Q3. It dived, as 61 investors sold EMR shares while 465 reduced holdings. 94 funds opened positions while 333 raised stakes. 433.10 million shares or 2.57% less from 444.54 million shares in 2016Q3 were reported. Central Commercial Bank invested in 1,600 shares or 0.02% of the stock. Bahl Gaynor Inc holds 0.26% or 374,991 shares in its portfolio. Moreover, Charter Trust has 0.58% invested in Emerson Electric Co. (NYSE:EMR). Tower Bridge Advsr owns 57,214 shares for 0% of their portfolio. Beck Mack Oliver Ltd Liability Com owns 24,483 shares. Prudential Public Ltd Limited Liability Company reported 846,896 shares. Segall Bryant Hamill Lc holds 0.08% or 58,924 shares in its portfolio. Breton Hill holds 0.32% or 22,512 shares. Midas Corp, a New York-based fund reported 27,000 shares. Moreover, Hm Payson has 0.19% invested in Emerson Electric Co. (NYSE:EMR) for 71,176 shares. Riverhead Capital Mngmt Limited Liability Corporation holds 10,080 shares or 0.03% of its portfolio. Epoch Invest Prtn Inc, New York-based fund reported 2.56 million shares. Cardinal Capital invested in 73,206 shares. Granite Inv Prns Lc invested in 17,520 shares. 800 are owned by Live Your Vision Ltd.

Since February 9, 2017, it had 0 buys, and 4 selling transactions for $2.97 million activity. $642,937 worth of Emerson Electric Co. (NYSE:EMR) was sold by Train Michael H. on Tuesday, February 21. 7,839 shares valued at $496,277 were sold by Pelch Steven J. on Friday, February 10. Purvis Edgar M Jr also sold $922,737 worth of Emerson Electric Co. (NYSE:EMR) shares. On Thursday, February 9 the insider DELLAQUILA FRANK J sold $910,063.

Kornitzer Capital Management Inc decreased Bio (NASDAQ:TECH) stake by 55,470 shares to 189,440 valued at $19.48M in 2016Q4. It also reduced Borg Warner Inc (NYSE:BWA) stake by 69,260 shares and now owns 151,660 shares. Sps Commerce Inc (NASDAQ:SPSC) was reduced too.

The stock increased 1.25% or $0.35 during the last trading session, reaching $28.25. About shares traded. Accelerate Diagnostics Inc (AXDX) has risen 147.12% since June 20, 2016 and is uptrending. It has outperformed by 130.42% the S&P500.

Since January 1, 0001, it had 3 insider buys, and 1 sale for $ activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: